Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging

PROCEDURE9 trials

Conditions

Adult Brain GlioblastomaCentral Nervous System LymphomaChildhood Brain NeoplasmGlioblastomaGlioblastoma, IDH-WildtypeGliosarcomaMalignant GliomaMetastatic Malignant Neoplasm in the Brain

Early Phase 1

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

CompletedNCT00978562

OHSU Knight Cancer InstituteChildhood Brain Neoplasm, Recurrent Childhood Brain Neoplasm

Start: 2009-08-31End: 2018-12-31Updated: 2022-08-03

Phase 2

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

TerminatedNCT00659126

OHSU Knight Cancer InstituteMetastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm

Start: 2006-11-16End: 2020-12-31Updated: 2023-09-07

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

RecruitingNCT06319027

ECOG-ACRIN Cancer Research GroupGlioblastoma, IDH-Wildtype

Start: 2024-04-11End: 2027-05-31Target: 100Updated: 2026-04-03

Unknown Phase

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

CompletedNCT00103038

OHSU Knight Cancer InstituteCentral Nervous System Lymphoma, Malignant Glioma, Metastatic Malignant Neoplasm in the Brain

Start: 2004-06-04End: 2016-06-10Updated: 2022-06-09

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

CompletedNCT00660543

OHSU Knight Cancer InstituteAdult Brain Glioblastoma

Start: 2006-12-31End: 2014-06-30Updated: 2017-05-16

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

TerminatedNCT02269111

Vanderbilt-Ingram Cancer CenterTumors Metastatic to Brain, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2015-04-30End: 2018-05-31Updated: 2018-05-29

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

CompletedNCT02359097

OHSU Knight Cancer InstituteGlioblastoma

Start: 2015-01-06End: 2021-03-12Updated: 2022-03-17

Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors

NCT02526511

Rutgers, The State University of New JerseyStage III Renal Cell Cancer, Stage II Renal Cell Cancer, Stage I Renal Cell Cancer +1

Start: 2015-04-15End: 2025-09-07Updated: 2023-04-11

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Active, not recruitingNCT03115333

ECOG-ACRIN Cancer Research GroupGliosarcoma, Recurrent Glioblastoma

Start: 2017-07-25End: 2027-05-07Updated: 2026-04-03

Related Papers

An Accelerated Spectroscopic MRI Metabolite Quantification Based on a Deep Learning Method for Radiation Therapy Planning in Brain Tumor Patients

Cancers2025-01-271 citations

Visualisation of normal and abnormal brain vasculature with different ferumoxytol doses.